
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+5
Palisade Bio (Nasdaq: PALI) is a biopharmaceutical company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. The Company believes that addressing the disruption of the intestinal barrier can fundamentally change the way diseases are treated and establish new standards of patient care. Palisade Bios lead program, PALI-2108 is a microbiota-activated PDE4 inhibitor prodrug being developed for the treatment of moderate-to-severe ulcerative colitis and is advancing toward the completion of IND-enabling studies and an IND filing. The Companys second lead program, PALI-1908, is being evaluated in preclinical development for the treatment of fibrostenotic Crohns Disease...
Therapeutics,drug development,gastrobiome,microbiome,surgery,cardiovascular,gastrointestinal,biotech,r&d,and covid-19
Palisade bio operates in the Pharmaceutical manufacturing industry.
Palisade bio's revenue is < 1m
Palisade bio has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.